StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30573% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Cumulative Phase 3 registrational clinical trials by Quarter

Cumulative Phase 3 registrational clinical trials (trials)

QuarterlyAnnual

Moderna Cumulative Phase 3 registrational clinical trials: 34.00 trials in Q2 2026, up 21.4% from a year earlier. That is the highest of the 34 quarters on record here.

Latest, Q2 2026
34.00
Period ended Jun 30, 2026
Change on a year earlier
+21.4%
28.00 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
1
ClinicalTrials.gov API v2 (ModernaTX, Inc.)

Where the Q2 2026 figure comes from

Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCumulative Phase 3 registrational clinical trials (trials)Year on yearSource
Q2 2026Jun 30, 202634.00+21.4%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2026Mar 31, 202633.00+17.9%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2025Dec 31, 202532.00+14.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2025Sep 30, 202530.00+20.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2025Jun 30, 202528.00+27.3%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2025Mar 31, 202528.00+40.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2024Dec 31, 202428.00+40.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2024Sep 30, 202425.00+47.1%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2024Jun 30, 202422.00+46.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2024Mar 31, 202420.00+42.9%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2023Dec 31, 202320.00+53.8%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2023Sep 30, 202317.00+30.8%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q2 2023Jun 30, 202315.00+25.0%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q1 2023Mar 31, 202314.00+55.6%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q4 2022Dec 31, 202213.00+62.5%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Q3 2022Sep 30, 202213.00+116.7%ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗

Cite this data

StockData. (2026). Moderna Cumulative Phase 3 registrational clinical trials, quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-cum-phase3

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.